Hyperspectral imaging in medical can also support surgeons by offering them information that鈥檚 invisible to the naked eye 鈥� in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon鈥檚 perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.
The global Hyperspectral Imaging in Medical market is projected to reach US$ 44 million in 2029, increasing from US$ 18 million in 2022, with the CAGR of 13.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyperspectral Imaging in Medical market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hyperspectral Imaging in Medical market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Headwall Photonics
Resonon
IMEC
EVK DI Kerschhaggl
Cubert
Galileo
Specim
Gooch & Housego
Surface Optics
Norsk Elektro Optikk A/S
Wayho Technology
BaySpec
Segment by Type
Visible + Near Infrared Light
Short-Wavelength Infrared
Others
Segment by Application
Diagnostic Centres
Hospitals
Research & Academic Centres
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hyperspectral Imaging in Medical report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Hyperspectral Imaging in Medical 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Visible + Near Infrared Light
1.2.3 Short-Wavelength Infrared
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Hyperspectral Imaging in Medical 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Centres
1.3.3 Hospitals
1.3.4 Research & Academic Centres
1.3.5 Pharmaceutical & Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperspectral Imaging in Medical 麻豆原创 Perspective (2018-2029)
2.2 Hyperspectral Imaging in Medical Growth Trends by Region
2.2.1 Global Hyperspectral Imaging in Medical 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hyperspectral Imaging in Medical Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Hyperspectral Imaging in Medical Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Hyperspectral Imaging in Medical 麻豆原创 Dynamics
2.3.1 Hyperspectral Imaging in Medical Industry Trends
2.3.2 Hyperspectral Imaging in Medical 麻豆原创 Drivers
2.3.3 Hyperspectral Imaging in Medical 麻豆原创 Challenges
2.3.4 Hyperspectral Imaging in Medical 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyperspectral Imaging in Medical Players by Revenue
3.1.1 Global Top Hyperspectral Imaging in Medical Players by Revenue (2018-2023)
3.1.2 Global Hyperspectral Imaging in Medical Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Hyperspectral Imaging in Medical 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hyperspectral Imaging in Medical Revenue
3.4 Global Hyperspectral Imaging in Medical 麻豆原创 Concentration Ratio
3.4.1 Global Hyperspectral Imaging in Medical 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperspectral Imaging in Medical Revenue in 2022
3.5 Hyperspectral Imaging in Medical Key Players Head office and Area Served
3.6 Key Players Hyperspectral Imaging in Medical Product Solution and Service
3.7 Date of Enter into Hyperspectral Imaging in Medical 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperspectral Imaging in Medical Breakdown Data by Type
4.1 Global Hyperspectral Imaging in Medical Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Hyperspectral Imaging in Medical Forecasted 麻豆原创 Size by Type (2024-2029)
5 Hyperspectral Imaging in Medical Breakdown Data by Application
5.1 Global Hyperspectral Imaging in Medical Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Hyperspectral Imaging in Medical Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Hyperspectral Imaging in Medical 麻豆原创 Size (2018-2029)
6.2 North America Hyperspectral Imaging in Medical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2018-2023)
6.4 North America Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyperspectral Imaging in Medical 麻豆原创 Size (2018-2029)
7.2 Europe Hyperspectral Imaging in Medical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2018-2023)
7.4 Europe Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyperspectral Imaging in Medical 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Hyperspectral Imaging in Medical 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hyperspectral Imaging in Medical 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Hyperspectral Imaging in Medical 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyperspectral Imaging in Medical 麻豆原创 Size (2018-2029)
9.2 Latin America Hyperspectral Imaging in Medical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyperspectral Imaging in Medical 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Hyperspectral Imaging in Medical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Hyperspectral Imaging in Medical 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Headwall Photonics
11.1.1 Headwall Photonics Company Detail
11.1.2 Headwall Photonics Business Overview
11.1.3 Headwall Photonics Hyperspectral Imaging in Medical Introduction
11.1.4 Headwall Photonics Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.1.5 Headwall Photonics Recent Development
11.2 Resonon
11.2.1 Resonon Company Detail
11.2.2 Resonon Business Overview
11.2.3 Resonon Hyperspectral Imaging in Medical Introduction
11.2.4 Resonon Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.2.5 Resonon Recent Development
11.3 IMEC
11.3.1 IMEC Company Detail
11.3.2 IMEC Business Overview
11.3.3 IMEC Hyperspectral Imaging in Medical Introduction
11.3.4 IMEC Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.3.5 IMEC Recent Development
11.4 EVK DI Kerschhaggl
11.4.1 EVK DI Kerschhaggl Company Detail
11.4.2 EVK DI Kerschhaggl Business Overview
11.4.3 EVK DI Kerschhaggl Hyperspectral Imaging in Medical Introduction
11.4.4 EVK DI Kerschhaggl Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.4.5 EVK DI Kerschhaggl Recent Development
11.5 Cubert
11.5.1 Cubert Company Detail
11.5.2 Cubert Business Overview
11.5.3 Cubert Hyperspectral Imaging in Medical Introduction
11.5.4 Cubert Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.5.5 Cubert Recent Development
11.6 Galileo
11.6.1 Galileo Company Detail
11.6.2 Galileo Business Overview
11.6.3 Galileo Hyperspectral Imaging in Medical Introduction
11.6.4 Galileo Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.6.5 Galileo Recent Development
11.7 Specim
11.7.1 Specim Company Detail
11.7.2 Specim Business Overview
11.7.3 Specim Hyperspectral Imaging in Medical Introduction
11.7.4 Specim Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.7.5 Specim Recent Development
11.8 Gooch & Housego
11.8.1 Gooch & Housego Company Detail
11.8.2 Gooch & Housego Business Overview
11.8.3 Gooch & Housego Hyperspectral Imaging in Medical Introduction
11.8.4 Gooch & Housego Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.8.5 Gooch & Housego Recent Development
11.9 Surface Optics
11.9.1 Surface Optics Company Detail
11.9.2 Surface Optics Business Overview
11.9.3 Surface Optics Hyperspectral Imaging in Medical Introduction
11.9.4 Surface Optics Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.9.5 Surface Optics Recent Development
11.10 Norsk Elektro Optikk A/S
11.10.1 Norsk Elektro Optikk A/S Company Detail
11.10.2 Norsk Elektro Optikk A/S Business Overview
11.10.3 Norsk Elektro Optikk A/S Hyperspectral Imaging in Medical Introduction
11.10.4 Norsk Elektro Optikk A/S Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.10.5 Norsk Elektro Optikk A/S Recent Development
11.11 Wayho Technology
11.11.1 Wayho Technology Company Detail
11.11.2 Wayho Technology Business Overview
11.11.3 Wayho Technology Hyperspectral Imaging in Medical Introduction
11.11.4 Wayho Technology Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.11.5 Wayho Technology Recent Development
11.12 BaySpec
11.12.1 BaySpec Company Detail
11.12.2 BaySpec Business Overview
11.12.3 BaySpec Hyperspectral Imaging in Medical Introduction
11.12.4 BaySpec Revenue in Hyperspectral Imaging in Medical Business (2018-2023)
11.12.5 BaySpec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Headwall Photonics
Resonon
IMEC
EVK DI Kerschhaggl
Cubert
Galileo
Specim
Gooch & Housego
Surface Optics
Norsk Elektro Optikk A/S
Wayho Technology
BaySpec
听
听
*If Applicable.
